BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2420244)

  • 21. Prognosis and treatment of bile duct carcinoma.
    Chung C; Bautista N; O'Connell TX
    Am Surg; 1998 Oct; 64(10):921-5. PubMed ID: 9764692
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prolonged palliation in carcinoma of the man hepatic duct junction.
    Terblanche J; Saunders SJ; Louw JH
    Surgery; 1972 May; 71(5):720-31. PubMed ID: 4112754
    [No Abstract]   [Full Text] [Related]  

  • 23. [Treatment of cancer of the gallbladder and bile duct].
    Koga A; Nakayama F
    Gan To Kagaku Ryoho; 1982 Sep; 9(9):1526-33. PubMed ID: 7184460
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radiotherapy of postoperative residual tumor of bile duct carcinoma.
    Kurisu K; Hishikawa Y; Miura T; Kanno H; Okamoto E
    Radiat Med; 1991; 9(2):82-4. PubMed ID: 1658858
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of carcinoma of the biliary system.
    Iwasaki Y; Ohto M; Todoroki T; Okamura T; Nishimura A
    Surg Gynecol Obstet; 1977 Feb; 144(2):219-24. PubMed ID: 835061
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Carcinoma of the gallbladder and bile ducts. A retrospective review.
    Dunbar LL; Adkins RB; Farringer J; Waterhouse G; O'Leary JP
    Am Surg; 1983 Feb; 49(2):94-104. PubMed ID: 6186171
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cholangiocarcinoma: advocate an aggressive operative approach with adjuvant chemotherapy.
    Kelley ST; Bloomston M; Serafini F; Carey LC; Karl RC; Zervos E; Goldin S; Rosemurgy P; Rosemurgy AS
    Am Surg; 2004 Sep; 70(9):743-8; discussion 748-9. PubMed ID: 15481288
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does additive radiotherapy after hilar resection improve survival of cholangiocarcinoma? An analysis in sixty-four patients.
    Verbeek PC; Van Leeuwen DJ; Van Der Heyde MN; Gonzalez Gonzalez D
    Ann Chir; 1991; 45(4):350-4. PubMed ID: 1648329
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The surgical treatment of malignant liver tumors].
    Patiutko IuI; Panakhov DM; Lagoshnyĭ AT; Kotel'nikov AG
    Khirurgiia (Mosk); 1992 Mar; (3):52-5. PubMed ID: 1279263
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Carcinoma of the extrahepatic bile ducts.
    Rodgers CM; Adams JT; Schwartz SI
    Surgery; 1981 Oct; 90(4):596-601. PubMed ID: 7281000
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Klatskin tumor--results of surgical therapy.
    Zovak M; Doko M; Glavan E; Hochstädter H; Roić G; Ljubicić N
    Coll Antropol; 2004 Jun; 28(1):317-23. PubMed ID: 15636089
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical significance of implantation metastases after surgical treatment of cholangiocarcinoma.
    Verbeek PC; Van der Heyde MN; Ramsoekh T; Bosma A
    Semin Liver Dis; 1990 May; 10(2):142-4. PubMed ID: 2162566
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patterns and relevant factors of tumor recurrence for extrahepatic bile duct carcinoma after radical resection.
    Park SW; Park YS; Chung JB; Kang JK; Kim KS; Choi JS; Lee WJ; Kim BR; Song SY
    Hepatogastroenterology; 2004; 51(60):1612-8. PubMed ID: 15532789
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic factors of surgical resection in middle and distal bile duct cancer: an analysis of 55 patients concerning the significance of ductal and radial margins.
    Sakamoto Y; Kosuge T; Shimada K; Sano T; Ojima H; Yamamoto J; Yamasaki S; Takayama T; Makuuchi M
    Surgery; 2005 Apr; 137(4):396-402. PubMed ID: 15800484
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cholangiocarcinoma: the impact of tumor location and treatment strategy on outcome.
    Heron DE; Stein DE; Eschelman DJ; Topham AK; Waterman FM; Rosato EL; Alden M; Anne PR
    Am J Clin Oncol; 2003 Aug; 26(4):422-8. PubMed ID: 12902899
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatocellular carcinoma with tumor thrombi in the bile duct.
    Wang HJ; Kim JH; Kim JH; Kim WH; Kim MW
    Hepatogastroenterology; 1999; 46(28):2495-9. PubMed ID: 10522026
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surgical strategy for the management of hilar bile duct cancer.
    Parc Y; Frileux P; Balladur P; Delva E; Hannoun L; Parc R
    Br J Surg; 1997 Dec; 84(12):1675-9. PubMed ID: 9448613
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extrahepatic bile duct carcinoma: a western experience with 118 consecutive patients.
    Doglietto GB; Alfieri S; Pacelli F; Mutignani M; Costamagna G; Carriero C; Di Giorgio A; Papa V
    Hepatogastroenterology; 2000; 47(32):349-54. PubMed ID: 10791187
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surgical treatment of proximal bile duct tumors.
    Gazzaniga GM; Faggioni A; Filauro M
    Int Surg; 1985; 70(1):45-8. PubMed ID: 2410390
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radical resection of hilar bile duct carcinoma and predictors of survival.
    Todoroki T; Kawamoto T; Koike N; Takahashi H; Yoshida S; Kashiwagi H; Takada Y; Otsuka M; Fukao K
    Br J Surg; 2000 Mar; 87(3):306-13. PubMed ID: 10718799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.